|
|
|
|
|
|
by the_watcher
3430 days ago
|
|
|
I think I agree with you from a policy perspective. However, the cost of a false negative has major PR implications (just wait for the first "I tried this algorithm and it misdiagnosed what turned out to be cancer") story. While I totally agree that those stories would be entirely unfair when looking at rates, that's not how it would play out in media response (and unfortunately, regulatory response). |
|
|